Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-26-004178
Filing Date
2026-05-20
Accepted
2026-05-20 16:47:56
Documents
54
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR MAR 2026 bioregenx_i10q-33126.htm   iXBRL 10-Q 624122
2 CERTIFICATION bioregenx_ex3101.htm EX-31 7362
3 CERTIFICATION bioregenx_ex3202.htm EX-32 3529
  Complete submission text file 0001683168-26-004178.txt   4129335

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE brgx-20260331.xsd EX-101.SCH 35229
5 XBRL CALCULATION FILE brgx-20260331_cal.xml EX-101.CAL 42280
6 XBRL DEFINITION FILE brgx-20260331_def.xml EX-101.DEF 146507
7 XBRL LABEL FILE brgx-20260331_lab.xml EX-101.LAB 297595
8 XBRL PRESENTATION FILE brgx-20260331_pre.xml EX-101.PRE 255175
58 EXTRACTED XBRL INSTANCE DOCUMENT bioregenx_i10q-33126_htm.xml XML 454229
Mailing Address 7407 ZIEGLER ROAD CHATTANOOGA TN 37421
Business Address 7407 ZIEGLER ROAD CHATTANOOGA TN 37421 (866) 770-4067
BIOREGENX, INC. (Filer) CIK: 0001593184 (see all company filings)

EIN.: 462836541 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56345 | Film No.: 261004746
SIC: 7370 Services-Computer Programming, Data Processing, Etc.
(CF Office: 06 Technology)